Founded in 1978, Biogen is a leading international biotechnology firm that has pioneered several breakthrough innovations such as a broad portfolio of medicines to take care of many sclerosis, the initial accepted treatment for spinal muscular atrophy, two co-formulated treatment options to deal with a defining pathology of Alzheimer’s condition,